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Abstract
Effective parenteral vaccines are available to control rabies in dogs. While such vaccines are
successfully used worldwide, the period between vaccine boosters required to guarantee
protection of the population against rabies varies between vaccines and populations. In Flo-
res Island, Indonesia, internationally and locally produced rabies vaccines are used during
annual vaccination campaigns of predominantly free-roaming owned domestic dogs. The
study objective was to identify the duration of the presence and factors associated with the
loss of adequate level of binding antibodies (�0.5 EU/ml) following rabies vaccination in a
domestic dog population on Flores Island. A total of 171 dogs that developed an antibody
titre higher or equal to 0.5 EU/ml 30 days after vaccination (D30), were repeatedly sampled
at day 90, 180, 270, and 360 after vaccination. On the day of vaccination (D0), an interview
was performed with dog owners to collect information on dog characteristics (age, sex, body
condition score (BCS)), history of rabies vaccination, kind of daily food, frequency of feeding,
and origin of the dog. Serum samples were collected and the level of antibodies was quantita-
tively assessed using ELISA tests. Dogs were categorized as having an adequate level of
binding antibodies (�0.5 EU/ml) or inadequate level of binding antibodies (<0.5 EU/ml) at
each time points examined. A total of 115, 72, 23, and 31 dogs were sampled at D90, D180,
D270, and D360, respectively, with the highest proportion of antibodies� 0.5 EU/ml (58%,
95% CI, 49–67%) at D90, which reduced gradually until D360 (35%, 95% CI, 19–52%). Multi-
variable logistic regression models showed that loss of adequate level of binding antibodies
is significantly associated with dogs having no history of vaccination or vaccination applied
more than 12 months before D0, being less than 12 months of age, and having a poor BCS.
These results highlight the importance of BCS regarding the immune response duration and
provide insights into frequency of vaccination campaigns required for the internationally avail-
able vaccine used on Flores Island. For dogs without vaccination history or vaccination being
applied more than 12 months before D0, a booster is recommended within 3 months (a larg-
est drop of antibodies was detected within the first 90 days) after the first vaccination to guar-
antee measurable protection of the population that lasts at least for one year.
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Author summary
Rabies is a zoonotic disease, caused by a lyssavirus, resulting in thousands of deaths every
year, particularly in low-resource endemic regions in Asia and Africa. High quality rabies
vaccines have been available since decades to guarantee protection of the dog population
against rabies. Furthermore, maintaining a high vaccination coverage and herd immunity
until the subsequent vaccination campaign is essential for preventing circulation of rabies
virus within dog populations. However, the percentage of dogs that maintain an adequate
level of rabies antibodies one year after vaccination and factors influencing such a mainte-
nance is unknown for the dog populations on Flores Island, Indonesia. This study aimed
at understanding the risk factors associated with loss of adequate level of binding antibod-
ies amongst vaccinated dogs that developed antibody titre�0.5 EU/ml after parenteral
vaccination, following a longitudinal study over one year. The study identified body con-
dition score of the dogs, their previous vaccination, and their age as factors that influence
the maintenance of an adequate level of antibodies. For dogs without previous vaccination
and vaccination being applied more than 12 months ago, a booster is recommended
within 3 months after the first vaccination to guarantee an antibody levels that lasts for at
least one year. In addition, a low BCS should be considered as one of the risk factors of los-
ing measurable immunity. Therefore, improving the dogs’ poor BCS should also be pro-
moted to enhance immune response and ensure longer presence of antibodies against
rabies.
Introduction
Rabies is one of the oldest zoonotic diseases and has a case fatality rate of almost 100% both in
animals and humans [1,2]. People become infected through close contact with saliva of
infected animals, mostly via bites [1]. More than 100,000 humans exposed to rabid animals are
reported annually worldwide, resulting in approximately 60,000 deaths [3]. Over 95% of these
cases were associated with rabid dogs [3]. Prevention of rabies in humans can be achieved by
post exposure prophylaxis, including wound treatment and vaccination after bite by a sus-
pected rabid animal [1]. However, the most effective and sustainable way is to eliminate the
disease by mass vaccination within the reservoir population, notably the domestic dog popula-
tions [4].
Vaccination against rabies in dogs is efficient and available since decades. It has been dem-
onstrated in various settings that rabies can be eliminated from a reservoir population by mass
vaccination. One of the first successful stories of a mass vaccination program in a dog popula-
tion occurred in the city of Memphis (Shelby County) in the United States in 1948, in which
the number of human cases reduced to zero within five months after a mass vaccination cam-
paign in dogs [5]. Other success stories of mass vaccination in dog population were reported
from Latin American countries [6], Africa [7,8], and Asia [9]. In Asia, for example, mass vacci-
nation of dogs successfully decreased the human rabies incidence in Bali Island, Indonesia [9],
Bhutan [10], and Philippines [11]. These success stories depend not only on well-organized
dog mass vaccination programmes and high vaccination coverage, but also on the effectiveness
of vaccines to protect dogs against rabies in natural setting [12].
Flores Island, Indonesia, has been endemic of canine rabies since 1998, and reports 15
human deaths annually [13]. With the objective of controlling rabies, annual dog vaccination
campaigns are publicly funded in which Rabisin vaccine (Boehringer Ingelheim) have been
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used in the last couple of years. Maintaining a high vaccination coverage and herd immunity
until the subsequent vaccination campaign is essential for preventing circulation of rabies
virus within dog populations. However, the duration of the maintenance of immunity in the
Flores Island dog populations have not been studied yet.
Although it is known that cellular immunity plays a role for the protection against rabies
after vaccination [14], the immune status of an individual can be only quantified in a practical
way by measuring the circulating antibodies. Rabies sero-prevalence studies have previously
been conducted in Asia and Europe [15,16,17,18]. These studies focused on determining the
pattern of immunogenicity amongst different dog age groups, however they lacked investiga-
tion of other risk factors associated with loss of adequate level of antibodies against rabies after
vaccination. Several studies examined factors influencing the development of immunity
against rabies after vaccination in dogs, and found that age at the time of vaccination, timing
of blood sampling, and breed of dogs were associated with the level of antibodies against rabies
[19–23]. However, none of these studies were dedicated to explore these aspects in free-roam-
ing domestic dogs (FRDD).
FRDD can be defined as being ownerless or owned dogs that are unconfined at least part of
the time. On Flores Island, Indonesia–as in most rabies endemic countries–dogs are predomi-
nantly kept as owned FRDD [24]. The owners typically feed their dogs with leftovers, such as
rice, for their daily food, which generally is of low protein value and not adequate for canine
nutrition [25]. As a consequence, most of the dogs have a poor body condition score (BCS). A
poor body condition score (BCS) is expected to negatively influencing the immune response
of dogs after vaccination, as it could be shown that the lymphocyte counts in dogs with lower
BCS are less than those dogs with ideal BCS [12].
The current study aimed at understanding the risk factors associated with loss of adequate
level of binding antibodies, taken as a measurable metric for their immunity, amongst vacci-
nated dogs that developed immunity after parenteral vaccination on Flores Island, following a
longitudinal study approach. The results of this study will inform policy makers to better plan
frequencies of vaccination campaigns and improve their effectiveness.
Materials and methods
Ethics statement
Approval to conduct the study was obtained from the Animal Ethics Commission of the Veter-
inary Medicine Faculty, Nusa Cendana University (Protocol KEH/FKH/NPEH/2019/009).
Informed consent for participation was obtained from dog owners before conducting the
study.
Study area
Blood sampling and questionnaire distribution were conducted in households with dogs in
rural (Pogon and Hepang) and urban (Habi) areas in Sikka Regency, Flores Island, Indonesia
between July 2018 and August 2019 (Fig 1). The regency was selected following an initial sur-
vey conducted by the principal author, which indicated the high prevalence of human rabies
on Island of Flores [24]. Sikka is located in the eastern part of Flores Island and covers an area
of 15,624 km2. The regency is divided into 351 villages, with a human population of more than
300,000 inhabitants (census data of 2010) and an owned dog population of greater than 37,000
[24]. Many of the villages in the regency are categorized as rural areas and are only accessible
by foot or with high-clearance vehicles or motor bikes. As in other regencies in Flores Island,
agriculture is the most important socio-economic activity (production of coconut, corn,
groundnut, cocoa, coffee, potato, and paddy), in which dogs are used to guard the crops. Most
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dogs are owned and roam freely day and night [26]. Dogs have a high cultural and economic
value in Flores Island, as they provide a source of animal protein in addition to their guarding
capacities. Dog meat is a popular menu item in certain traditional ceremonies of the island.
Sampling design
Since this study was part of a larger dog ecology study, the sampling design was driven by the
necessity to study the complete dog network in a delimited area [27,28]. Therefore, we defined
an area of 1 km2, both in rural and urban sites, where we aimed at including all dogs. During
the blood sampling, sick and/or pregnant dogs were excluded from the study to avoid miscar-
riage due to stress.
Data collection
Blood samples. At day 0 (D0), dog blood samples were taken from 256 dogs and each dog
was vaccinated against rabies immediately after the blood sampling. The dogs were vaccinated
intramuscularly with 0.5 ml of Rabisin vaccine (Boehringer Ingelheim). Of 256 sampled dogs
at D0, 187 (73.1%) dogs could be followed-up 30 days afterwards (D30), of which 171 (91.4%)
dogs had developed virus binding antibody levels of�0.5 Equivalent Unit per ml serum (EU/
ml). As the aim of the study was to identify risk factors for losing immunity defined as an ade-
quate binding antibody titre�0.5EU/ml at different time point amongst vaccination, the anal-
ysis was conducted prospectively on the 171 dogs that developed an antibody titre�0.5 EU/ml
at D30. Blood was further sampled from the exact same dogs at 90 (D90), 180 (D180), 270
(D270), and 360 (D360) days after vaccination, whenever the dog was present for sampling.
Blood (3–5 ml) was sampled from v. cephalica and put into a blood tube. The blood tubes were
transported to the animal health laboratory of Agricultural Department of Sikka Regency. At
the same day of sampling, the full blood was separated by centrifugation to extract the serum,
which was then dispensed into 3 ml labelled Eppendorf tubes. The tubes were stored at +4˚C
until shipping to veterinary laboratory (Disease Investigation Center, Denpasar) in Bali, where
ELISA (Enzyme linked immunosorbent assays) tests were performed to determine the rabies
antibody titres.
Fig 1. Study area. Base layer: https://www.statsilk.com/maps/download–free–shapefile–maps.
https://doi.org/10.1371/journal.pntd.0009688.g001
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Dog characteristics
Information on dog characteristics, history of vaccination, kind of daily food, frequency of
feeding and BCS was collected during the interviews at D0. The BCS ranged from 1–5, which
was later on categorized as poor for values 1–2 and good for values 3–5 for the data analysis.
During the following visits, the number of study dogs culled, sold, pregnant, sick, unable to
handle, or absent from home during the visit–and therefore not sampled at that time point–
was recorded. The interview were conducted in Bahasa by the researcher team.
Laboratory tests
Serum samples were tested for the presence of rabies antibodies using a Rabies ELISA kit pro-
duced by Pusvetma, Surabaya, Indonesia (http://pusvetma.ditjenpkh.pertanian.go.id/main.
php?page=detail_produk&id=28). This ELISA kit was validated against ELISA Platelia II
Rabies kit (Bio-Rad, France) for the detection of rabies binding antibodies, with sensitivity,
specificity, and Kappa coefficient being 96.8%, 73.5%, and 0.68, respectively [29]. Samples
were tested following the manufacturer’s instructions. In brief, serum samples were inactivated
at 56˚C for 30 minutes to inactivate potential pathogens that contaminated samples and may
harm laboratory technicians. Each sample was diluted by mixing of a 2.5 μl serum and 247.5 μl
PBS-Tween and 100 μl per sample were distributed in one well each of microplates coated
with whole rabies virus (Pasteur Virus strain). The microplate was sealed and incubated at
37˚C for 60 minutes and then washed four times with PBS-Tween. Afterwards, conjugate pro-
tein A labelled peroxidase was added into wells of microplate (100 μl/well) and sealed. The
microplate was incubated at 37˚C for 60 minutes and then washed four times with PBS-Tween.
Substrate solution was added 100 μl per well. The microplate was placed in dark room for
approximately 10 minutes, before stopper solution was added. Optical density was measured
at 405 nm with an ELISA reader. Samples were categorized as negative, i.e. having inadequate
level of binding antibodies, for ELISA if the titre was below 0.5 EU/ml.
Statistical analysis
Descriptive statistics were performed to describe the dog population characteristics for each
blood sampling time point (D30, D90, D180, D270 and D360). The proportion of dogs having
lost adequate level of binding antibodies at each time point was calculated by dividing the
number of dogs with a negative ELISA test by the respective number of sampled dogs. Chi-
square test was used to compare the proportion of dogs losing adequate level of rabies binding
antibodies in regards to the dog individual characteristics. The association between investi-
gated factors (Table 1, independent variables) and loss of adequate level of binding antibodies
after vaccination (outcome variable) was assessed using univariable logistic regression analyses
for each time point separately. Four multivariable logistic regression analyses (one each per
time point) were subsequently conducted to determine the influence of each independent vari-
able to the outcome after adjusting for other variables. All independent variables that had p-
values lower than or equal to 0.25 in the univariable analyses were subsequently included in
the initial models for the multivariable analyses [30]. Prior to the multivariable analyses, multi-
collinearity between the independent variables (all of categorical nature) selected from the uni-
variable analyses were checked using Chi-Square tests. For correlated variables (Chi-Square
Test p-value <0.05), the variable which showed the higher association with the outcome vari-
able was considered in the multivariable analyses while the other one was excluded. The final
multivariable logistic models were derived by backward stepwise elimination in which vari-
ables with a p-value > 0.05 were excluded one-by-one in each step. The Hosmer-Lemeshow
goodness-of-fit test was performed to determine the fit of the final models to the data [30]. The
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final models were considered a good fit for the data if the p-value of the Hosmer-Lemeshow
test was greater than 0.05. SPSS version 19 was used for data analysis.
Results
Dog characteristics
The demographic characteristics of the 171 dogs having built an adequate level of binding anti-
bodies at the start of the study (D30) is provided in Table 1. The majority of the dogs was
female (69.0%), aged less than 12 months (58.5%), and had either no previous vaccination or
was vaccinated more than 12 months before D0 (67.8%) according to the owners statements.
Most dogs were local breed (99.4%), fed with leftovers (93.0%), and had a poor BCS of less
than 3 (55.6%). These characteristics were comparable for each blood sampling time point,
except for sampling D270 where more males were sampled than females (Tables 2 and 3).
Table 1. Demographic characteristics of dog surveyed in Flores Island, Indonesia at day 30 after vaccination
(n = 171).





<12 months 100 58.5
> = 12 months 71 41.5
Breed:





History of rabies vaccination before D0a:
<12 months 55 32.2
Never or >12 months 116 67.8
Origin of dogs:
Born in house 83 48.5
Given or bought 88 51.5




< 3 times per day 77 45.0
> = 3 times per day 94 55.0
Body condition score c:
Poor 95 55.6
Good 76 44.4
a D0 is the day of vaccination within this study.
bOther daily food like rice, corn, fish.
cBCS was range 1–5 which was categorized as poor if score less than 3 and good if score 3–5.
https://doi.org/10.1371/journal.pntd.0009688.t001
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Table 2. Frequency (n) and percentage (n/N) of dogs losing adequate level binding antibodies 90 (D90) and 180 (D180) days after vaccination, stratified by different
demographic characteristics of the dogs. The influence of demographic parameters were explored by univariable logistic regression analyses.
























Male 34 16 47.1 1.36 0.61–
3.05
20 10 50.0 0.85 0.30–
2.40
Female 81 32 39.5 1.00 52 28 53.8 1.00
Agea: 0.037 0.011
<12 months 66 33 50.0 2.27 1.04–
4.92
37 25 67.6 3.53 1.33–
9.32
> = 12 months 49 15 30.6 1.00 35 13 37.1 1.00
Breed: na na
Local breed 115 48 41.7 72 38 52.8




Urban 46 16 34.8 1.00 23 11 47.8 1.00
Rural 69 32 45.1 1.62 0.75–
3.50






<12 months 40 11 27.5 1.00 30 8 33.3 1.00
Never / > = 12
months
75 37 49.3 2.57 1.12–
5.88
42 30 62.5 3.33 1.19–
9.34
Origin of dogs: 0.605
g
0.177
Born in house 54 24 44.4 1.00 30 13 43.3 1.00
Given or bought 38 16 42.1 0.90 0.39–
2.10
42 25 59.5 1.92 0.74–
4.97
Kind of daily food: 0.078 g 0.378
Leftovers 106 47 44.3 6.37 0.77–
52.77
68 35 51.5 0.35 0.04–
3.57
Otherd 9 1 11.1 1.00 4 3 75.0 1.00
Frequency of food: 0.618 g 0.487
<3 times per day 45 18 40.0 1.00 37 21 56.8 1.00
> = 3 times per
day
70 30 42.9 2.67 0.23–
30.80







Poor 62 32 51.6 2.40 1.11–
5.19
47 29 61.7 2.86 1.05–
7.84
Good 52 16 30.8 1.00 25 9 36.0 1.00
OR = Odds ratio; CI = Confidence interval; na = no statistic are computed because 100% of dogs are local breeds; p–value shown in bold represents p< = 0.25; these
variables were used in the subsequent multivariable logistic regression analysis.
aExclude from subsequent multivariable logistic regression analysis at D90 as the variable age and residential of dogs were detected to be significantly correlated with
history of vaccination and BCS, respectively (p–value<0.05).
bExclude from subsequent multivariable logistic regression analysis at D180 as the variable history of vaccination was detected to be significantly correlated with age (p–
value<0.05).
c D0 is the day of vaccination in this study
dOther daily food include rice, corn, or fish.
eBCS was range 1–5 which was categorized as poor if score less than 3 and good if score 3–5.
fRabies binding antibody titre of < 0.5EU/ml.
gFisher x2 square test
https://doi.org/10.1371/journal.pntd.0009688.t002
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Table 3. Frequency (n) and percentage (n/N) of dogs losing adequate level binding antibodies 270 (D270) and 360 (D360) days after vaccination, stratified by differ-
ent demographic characteristics of the dogs. The influence of demographic parameters were explored by univariable logistic regression analyses.
























Male 19 11 57.9 0.46 0.04–
5.26
7 5 71.4 1.36 0.61–
3.05
Female 4 3 75.0 1.00 24 15 62.5 1.00
Age: 0.017� 0.052�
<12 months 15 12 80.0 12.00 1.56–
92.29
13 11 84.6 2.27 1.04–
4.92
> = 12 months 8 2 25.0 1.00 18 9 50.0 1.00
Breed: 1.000� 0.645�
Local breed 22 13 59.1 Na 30 19 63.3
Other 1 1 100 1 1 100.0
Residential area: 0.400� 0.477�
Urban 12 6 50.0 1.00 14 8 57.1 1.62 0.75–
3.50
Rural 11 8 72.7 2.67 0.47–
15.25







<12 months 4 1 25.0 1.00 1.14–
5.49
7 2 28.6 2.50 1.14–
5.49
Never / > = 12
months
19 13 68.4 6.50 0.56–
76.17
24 18 75.0 1.00
Origin of dogs: 0.657� 0.532�
Born in house 16 9 56.3 1.00 13 12 66.7 1.00
Given or
bought
7 5 71.4 1.94 0.29–
13.19





Leftovers 19 13 68.4 6.5 0.55–
76.18
28 17 60.7 6.37 0.77–
2.77






15 9 62.5 1.11 0.19–
6.49
16 10 66.7 1.00
> = 3 times per
day





Poor 12 10 83.3 8.75 1.24–
61.68
16 13 81.3 2.40 1.11–
5.19
Good 11 4 36.4 1.00 15 7 46.7 1.00
OR = Odds ratio; CI = Confidence interval; na = no statistic are computed because 100% of dogs are local breeds
�Fisher x2 square test; p–value shown in bold represents p< = 0.25; these variables were used in the subsequent multivariable logistic regression analysis.
aD0 is the day of vaccination within this study
bOther daily food like rice, corn, or fish.
cBCS was range 1–5 which was categorized as poor if score less than 3 and good if score 3–5.
dRabies binding antibody titre of < 0.5EU/ml.
https://doi.org/10.1371/journal.pntd.0009688.t003
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Loss of adequate level of binding antibodies after vaccination
A total of 115, 72, 23, and 31 dogs were sampled at D90, D180, D270, and D360, respectively.
The highest proportion of dogs maintaining binding antibody titres�0.5EU/ml was observed
at D90 (58%, 95% CI: 49–67%), and then reduced gradually until D360 (35%, 95% CI: 19–
52%) after vaccination (Fig 2).
The loss of adequate level of binding antibodies after vaccination differed among dog char-
acteristics according to the univariable analyses (Tables 2–4). At each time point, the propor-
tion of dogs losing adequate level of binding antibodies was significantly higher in dogs
younger than 12 months compared with dogs aged 12 months or more (p<0.05). Among dogs
younger than 12 months, the proportion of dogs having lost adequate level of binding
Fig 2. Percentage of dogs developed binding antibody titres�0.5EU/ml at days 90 (n = 115), 180 (n = 72), 270
(n = 23), and 360 (n = 32) after vaccination surveyed in Flores Island, Indonesia in 2018–2019. The dogs developed
binding antibody titres�0.5EU/ml at day 30 (n = 171) were taken as study population.
https://doi.org/10.1371/journal.pntd.0009688.g002
Table 4. Determinants associated with loss of adequate level of binding antibodies 90, 180, 270 and 360 days after rabies vaccination in dogs on Flores Island, Indo-
nesia, using multivariable logistic regression analysis. All dogs showed an adequate rabies binding antibody titre of� 0.5EU/ml 30 days after vaccination.
Variables Day 90 (N = 115) Day 180 (N = 72) Day 270 (N = 23) Day 360 (N = 31)
OR (95% CI) p-value OR (95% CI) p-value OR (95% CI p-value OR (95% CI p-value
Age:
<12 months 3.63 (1.33–9.99) 0.012 14.51 (1.29–172.97) 0.034
> = 12 months 1.00 1.00
History of rabies vaccination before D0a:
> = 12 months 2.39 (1.02–5.57) 0.044 2.3 8.69 (1.08–70.16) 0.043
Never / <12 months 1.00 1.00
Body condition score (BCS)b:
Poor 2.32 (1.06–5.09)c 0.036 2.98 (1.03–8.61) 0.044 10.69 (0.93–122.63) 0.057 5.68 (0.92–35.09) 0.062
Good 1.00 1.00 1.00 1.00
OR = Odds ratio; CI = Confidence interval.
aD0 is the day of vaccination within this study
bBCS was range 1–5 which was categorized as poor if score less than 3 and good if score 3–5.
cInformation on the BCS was missed for 1 dog
The Hosmer–Lemeshow goodness–of–fit test p–value for the model day 90, 180, 270, and 360 was 1.00, 0.99, 0.52, and 0.49, respectively
https://doi.org/10.1371/journal.pntd.0009688.t004
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antibodies was found to be 50.0% (95% CI: 38–62%) at D90 and increased thereafter until the
highest proportion at D360 (84.6%, 95% CI: 59–93%) (Tables 2 and 3). In comparison, for
dogs older than 12 months, loss of adequate level of binding antibodies was observed in 30.6%
(95% CI: 18–44%) of the dogs at D90 and 50.0% (95% CI: 27–73%) at D360. Furthermore,
among dogs without history of vaccination or those having been vaccinated more than 12
months before D0, a higher proportion lost adequate level of binding antibodies compared to
their counterparts, but the difference was only statistically significant at D90, D180, and D360.
Amongst dogs without history of vaccination, the proportion of dogs losing adequate level of
binding antibodies was found to be 49.3% (95% CI: 38–61%) at D90 and increased to the high-
est proportion at D360 (75.0%; 95% CI: 58–92%) (Tables 2 and 3), whereas for dogs having
been vaccinated less than 12 months before D0 these proportions were found to be 27.5%
(95% CI: 14–41%) and 28.6% (95% CI: 9–76%), respectively. Similarly, the BCS was detected
as significant parameter influencing the loss of adequate level of binding antibodies after vacci-
nation for each time point. The proportion of dogs having lost adequate level of binding anti-
bodies in dogs with a BCS lower than 3 was found to be 51.6% (95% CI: 39–64%), 61.7% (95%
CI: 48–76%), 83.3% (95% CI: 49–92%), and 81.3% (95% CI: 58–90%) at D90, D180, D270, and
D360, respectively, compared to 30.8% (95% CI: 18–43%), 36.0% (95% CI: 17–55%), 36.4%
(95% CI: 13–74%), and 46.7% (95% CI: 21–72%) in those with a BCS equal or higher than 3.
The proportion of dogs losing adequate level of binding antibodies for dogs in rural areas was
higher than dogs in urban areas at each blood sampling time point, but the differences were
not statistically significant (Tables 2 and 3). The proportion of dogs losing adequate level of
binding antibodies among dogs that were obtained as gifts (given by relative families) or
bought from traditional markets tended to be larger at D180 and D270 and lower at D90 and
D360 compared to their counterparts, but these differences were found to be statistically non-
significant. The influence of breed could not be analysed due to the very low number of dogs
being other than local breed.
Significant association between independent variables were detected for age and history of
vaccination (Chi-Square Test p-value = 0.006 and<0.001 for the D90 and D180 model, respec-
tively), between residential area of dogs and history of vaccination (Chi-Square Test p-
value < 0.001 for the D180 model), and between residential area of dogs and BCS (Chi-Square
Test p-value < 0.001 for the D90 model). The variables of age and residential area of dogs at
D90 and history of vaccination at D180 were thus excluded from subsequent multivariable
analyses (Table 2). No significant association between independent variables were observed
for the D270 and D360 model (Chi-Square Test p-value >0.05).
The multivariable logistic regression models showed that the proportion of dogs losing ade-
quate level of binding antibodies was significantly and positively associated with dogs without
history of vaccination or having been vaccinated more than 12 months before D0, dogs less
than 12 months, and dogs with poor BCS (Table 4). The significance of these factors depends
on the time point of blood samplings. For example, the results for D90 showed a significant
association with the BCS and the history of vaccination before D0. Dogs with poor BCS were
two times more likely (OR = 2.32; 95% CI = 1.06–5.09) to lose adequate level of binding anti-
bodies compared to those dogs with good BCS. Similarly, dogs without history of vaccination
or having been vaccinated more than 12 months before D0 were two times more likely
(OR = 2.39; 95% CI = 1.02–5.57) to lose adequate level of binding antibodies compared to
their counterparts. Age and history of vaccination before D0 had a significant contribution on
the proportion of dog losing adequate level of binding antibodies at D270 and D360, respec-
tively. BCS was the only variable that was associated with loss of adequate level of binding anti-
bodies after rabies vaccination at each time point, although for D270 and D360 the p-value
was slightly above the defined threshold of being statistically significant (Table 4).
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Loss of follow-up
Of the 171 immune dogs in the cohort (those developed binding antibody titres�0.5EU/ml at
D30), 56 (32.7%), 99 (57.9%), 147 (85.9%), and 138 (80.7%) were excluded from the analysis at
D90, D180, D270, and D360, respectively. The reasons for the lost follow-up include the
absence of dog owners and/or dogs at home during the time of the visit, the dog could not be
handled, pregnant, sick, death of the dog due to diseases and culling for meat source purpose.
Discussion
In this longitudinal study, we investigated antibody levels after rabies vaccination in FRDD
from 30 up to 360 days after vaccination under field conditions in both urban and rural areas
in Flores Island Indonesia. We found that the proportion of dogs having an adequate level of
rabies binding antibodies out of those that developed such a level 30 days after vaccination,
dropped massively after 60 days (D90) to 58%, and then further at each time point of investiga-
tion to 35% at D360. The trend of reducing rabies antibodies after vaccination is well docu-
mented in the literature and those findings overlap with what was found in the present study
[12,17,31–34]. A study conducted in Bali, Indonesia, found that the proportion of dogs having
a titre higher than 0.5 IU/ml reduced from >90% to 60–80% at 30 and 360 days after vaccina-
tion, respectively [12]. Similarly, Minke et al [34] studied the antibody titre in a group of 30
laboratory dogs vaccinated with Rabisin rabies vaccine and found that the proportion of dogs
with a titre� 0.5 IU/ml declined sharply from 93% at 28 days to 40% at 120 days post vaccina-
tion. Furthermore, Suzuki et al [32] studied the immune response of 236 vaccinated domestic
dogs under field condition in Bolivia and found that the proportion of dogs with a protective
antibodies seven months after vaccination was only 58%.
The natural loss of rabies antibodies in dogs after vaccination [32] can be influenced by
many factors, such as health status of vaccinated dogs [12], type of the vaccine used [34], and
age of the dogs at the time of vaccination [21]. In the current study, we demonstrated that dogs
aged less than one year at the time of vaccination were more likely to lose adequate level of
binding antibodies at D180 and D270 compared to their counterparts. It is well documented
in the literature that dogs less than one year of age have an increased risk of having a poor anti-
body response [19–21]. Two factors could contribute to this finding. First, the maternal anti-
bodies titre received from vaccinated dams limits effective immune response in puppies
[35,36], and it is common in Flores Island that dog owners vaccinate their reproductive female
dogs [24]. Second, younger dogs have a lower chance to having already received one or several
vaccine doses before the start of our study, depending on the frequency of rabies vaccination
campaigns undertaken in the region. In Sikka Regency, vaccination campaigns are conducted
annually, with the aim of vaccinating all dogs aged more than three months once per year.
Dogs born during or after the annual vaccination campaign will be vaccinated the following
year, which is the majority of those aged less than one year at the time of vaccination in our
study. As a consequence, dogs aged less than one year received their first dose of rabies vaccine
at D0, while their counterparts probably have already been vaccinated in the past. This is in
line with our finding that the reported history of vaccination significantly influenced the loss
of adequate level of binding antibodies after vaccination for some time points investigated
(D90 and D360). The presence of T-cell memory that have been activated in the previous vac-
cination, contributes to a more rapid and profound immune response in dogs with previous
vaccination [37]. As a consequence, higher levels of antibodies are produced after booster vac-
cination that then maintain for a longer duration at a level>0.5 EU/ml [19,21].
Our study highlights the importance of BCS on the immune response of dogs after vaccina-
tion. Dogs with low BCS were more likely to lose adequate level of binding antibodies than
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their counterpart. Early loss of adequate level of binding antibodies in dogs with low BCS
score could be related with a number of factors such as parasitic burden, nutritional and gen-
eral health status [12,38,39]. Parasitic infection and malnutrition is common in FRDD in Flo-
res Island, as it is in other rabies endemic areas in developing countries, where dog owners
may neither routinely apply anti-parasite treatments nor feed the dogs with adequate food
[40]. Our study found that 93% of dog owners stated to daily feed their dogs with leftovers,
such as rice, which generally is of low protein value compared to adequate nutrition for
canines [25]. This finding suggests that the maintenance of adequate level of binding antibod-
ies following rabies vaccination depends on the nutritional and health status of FRDD, even
for vaccination with high quality vaccines (such as Rabisin).
We found that the majority (65%) of dogs that developed binding antibody titre�0.5 EU/
ml at D30 failed to maintain this level until 360 days after rabies vaccination. This proportion
is higher than the previous study carried out on Bali Island, Indonesia, where only 20–40% of
vaccinated dogs were observed to lose neutralizing antibodies until D360 [12]. The difference
between the two studies may have occurred due to different test systems used, which was an
ELISA in the current study compared to the fluorescent antibody virus neutralisation (FAVN)
test in the study in Bali [12]. The FAVN test is a serum neutralization test with higher resource
demands than for the ELISA [41], however with higher sensitivity for antibody detection com-
pared to ELISA, depending on the threshold used [42,43]. Another reason for the lower pro-
portion of protected dogs at D360 compared to the study in Bali [12] might lay in the
difference of the dog management and BCS in the study populations, with dogs in Bali most
probably have a higher BCS than dogs kept in Flores due to higher average income of the
owners.
Furthermore, the present study found that at D90, almost 50% of dogs without reported
vaccination history has binding antibody levels <0.5 EU/ml (Table 2). The drop of the anti-
body level below the threshold of 0.5 EU/ml [44] does not automatically lead to a loss of immu-
nity, as documented by Dodds et al [14] and Aubert [45]. Dodds et al [14] reported that 80%
of vaccinated dogs without detectable antibodies were fully protected against a rabies-virus
challenge. Aubert [45] demonstrated that animals developing rabies neutralizing antibodies
above a threshold of 0.5 IU/ml after rabies vaccination, have a high probability of surviving
after a contact with rabies virus, regardless of the level of neutralizing antibodies at the time of
exposure. This phenomenon is due to the shift of humoral towards memory cellular immune
response developed by T and B lymphocytes, which are responsible for a faster and more effec-
tive immune response in the event of rabies virus exposure [14]. We therefore underestimate
the actual immunity of the dogs when focusing on the assessment of the humoral response
only, which is however the method applicable in practice. Therefore, in order to guarantee a
measurable immune response that last for at least one year, revaccination within three months
after the first vaccination is highly recommended in dogs without any previous vaccination.
A limitation of the current study is the high number of dogs lost for the followed-up after
D30, which lead to a wide confidence interval of immunity coverage over time (Fig 2). In addi-
tion, to have a complete understanding on the impact of different type vaccines on the
immune response, it would be interesting to compare the humoral response obtained in dogs
vaccinated with locally produced vaccines with those in dogs vaccinated with internationally
produced vaccines in a future study.
Conclusion
The results of this study provide knowledge on the loss of adequate level of rabies binding anti-
bodies of FRDD and on risk factors associated with it, from 30 to 360 days after vaccination.
PLOS NEGLECTED TROPICAL DISEASES Loss of binding antibodies against rabies in a vaccinated dog population
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0009688 September 7, 2021 12 / 15
The results highlight the importance of BCS, vaccination history, and age of dogs for the main-
tenance of an adequate level of rabies binding antibodies and provide insights into required
frequency of rabies vaccination campaigns in FRDD on Flores Island. For dogs without vacci-
nation history and vaccination being applied more than 12 months before D0, a booster is rec-
ommended within 3 months after the first vaccination to guarantee development of detectable
antibodies lasting for at least one year. In addition, good dog management should be recom-
mended to improve BCS of the animals, which would enhance maintenance of binding
antibodies.
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dogs in an African city interrupts rabies transmission and reduces human exposure. Sci Transl Med.
2017; 9: 1–10.
PLOS NEGLECTED TROPICAL DISEASES Loss of binding antibodies against rabies in a vaccinated dog population
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0009688 September 7, 2021 13 / 15
9. Putra AAG, Hampson K, Girardi J, Hiby E, Knobel D, Mardiana IW, et al. Response to a rabies epi-
demic, Bali, Indonesia, 2008–2011. Emerg Infect Dis. 2013; 19: 648–651. https://doi.org/10.3201/
eid1904.120380 PMID: 23632033
10. Tenzin, Ward MP. Review of Rabies Epidemiology and Control in South, South East and East Asia:
Past, Present and Prospects for Elimination. Zoonoses Public Health. 2012; 59: 451–467. https://doi.
org/10.1111/j.1863-2378.2012.01489.x PMID: 23180493
11. Miranda LM, Miranda ME, Hatch B, Deray R, Shwiff S, Roces MC, et al. Towards Canine Rabies Elimi-
nation in Cebu, Philippines: Assessment of Health Economic Data. Transbound Emerg Dis. 2017; 64:
121–129. https://doi.org/10.1111/tbed.12350 PMID: 25885005
12. Morters MK, McKinley TJ, Horton DL, Cleaveland S, Schoeman JP, Restif O, et al. Achieving Popula-
tion–Level Immunity to Rabies in Free–Roaming Dogs in Africa and Asia. PLoS Negl Trop Dis. 2014; 8:
1–12 https://doi.org/10.1371/journal.pntd.0003160 PMID: 25393023
13. Wera E. Socio–economic modelling of rabies control in Flores Island, Indonesia. PhD Thesis. Wagenin-
gen: Wageningen University. 2017. Available from: https://library.wur.nl/WebQuery/wda/2205208
14. Dodds WJ, Larson LJ, Christine KL, Schultz RD. Duration of immunity after rabies vaccination in dogs:
The Rabies Challenge Fund research study. Can J Vet Res. 2020; 84: 153–158. PMID: 32255911
15. Shimazaki Y, Inoue S, Takahashi C, Gamoh K, Etoh M, Kamiyama T, et al. Immune Response to Japa-
nese Rabies Vaccine in Domestic Dogs. J Vet Med B Infect Dis Vet Public Health. 2003; 50: 95–98.
https://doi.org/10.1046/j.1439-0450.2003.00627.x PMID: 12675902
16. Tepsumethanon W, Polsuwan C, Lumlertdaecha B, Khawplod P, Hemachudha T, Chutivongse S, et al.
Immune response to rabies vaccine in Thai dogs: A preliminary report. Vaccine. 1991; 9: 627–630.
https://doi.org/10.1016/0264-410x(91)90186-a PMID: 1950096
17. Pimburage RMS, Gunatilake M, Wimalaratne O, Balasuriya A, Perera KADN. Sero–prevalence of virus
neutralizing antibodies for rabies in different groups of dogs following vaccination. BMC Vet Res. 2017;
13. https://doi.org/10.1186/s12917-016-0929-8 PMID: 28061787
18. Delgado S, Cármenes P. Immune response following a vaccination campaign against rabies in dogs
from northwestern Spain. Prev Vet Med. 1997; 31: 257–261. https://doi.org/10.1016/s0167-5877(96)
01113-0 PMID: 9234449
19. Mansfield KL, Sayers R, Fooks AR, Burr PD, Snodgrass D. Factors affecting the serological response
of dogs and cats to rabies vaccination. Vet Rec. 2004; 154: 423–426. https://doi.org/10.1136/vr.154.
14.423 PMID: 15119893
20. Kennedy LJ, Lunt M, Barnes A, McElhinney L, Fooks AR, Baxter DN, et al. Factors influencing the anti-
body response of dogs vaccinated against rabies. Vaccine. 2007; 25: 8500–8507. https://doi.org/10.
1016/j.vaccine.2007.10.015 PMID: 18006120
21. Berndtsson LT, Nyman AK, Rivera E, Klingeborn B. Factors associated with the success of rabies vac-
cination of dogs in Sweden. Acta Vet Scand. 2011; 53:1–7. https://doi.org/10.1186/1751-0147-53-1
PMID: 21232109
22. Nodari ER, Alonso S, Mancin M, Nardi MD, Hudson–Cooke S, Veggiato C, et al. Rabies Vaccination:
Higher Failure Rates in Imported Dogs than in those Vaccinated in Italy. Zoonoses Public Health. 2017;
64: 146–155. https://doi.org/10.1111/zph.12268 PMID: 27152896
23. Wallace RM, Pees A, Blanton JB, Moore SM. Risk factors for inadequate antibody response to primary
rabies vaccination in dogs under one year of age. PLoS Negl Trop Dis. 2017; 11: e0005761. https://doi.
org/10.1371/journal.pntd.0005761 PMID: 28759602
24. Wera E, Mourits MCM, Hogeveen H. Uptake of rabies control measures by dog owners in Flores Island,
Indonesia. PLoS Negl Trop Dis. 2015; 9:1–23. https://doi.org/10.1371/journal.pntd.0003589 PMID:
25782019
25. Bontempo V. Nutrition and Health of Dogs and Cats: Evolution of Petfood. Vet Res Commun. 2005; 29:
45–50. https://doi.org/10.1007/s11259-005-0010-8 PMID: 16244924
26. Wera E, Velthuis AGJ, Geong M, Hogeveen H. Costs of Rabies Control: An Economic Calculation
Method Applied to Flores Island. Plos One. 2013; 8: 1–15 https://doi.org/10.1371/journal.pone.
0083654 PMID: 24386244
27. Warembourg C, Wera E, Odoch T, Bulu PM, Berger–González M, Alvarez D, et al. Comparative Study
of Free–Roaming Domestic Dog Management and Roaming Behavior Across Four Countries: Chad,
Guatemala, Indonesia, and Uganda. Front Vet Sci. 2021;8.
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